• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Skinovation Pharm

Skinovation Pharm

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: 9 beauty products for under $30 that the experts recommend

    UPDATE: 9 beauty products for under $30 that the experts recommend

  2. UPDATE: 9 beauty products for under $30 that the experts recommend

    UPDATE: 9 beauty products for under $30 that the experts recommend

  3. ‘The Imitation Game’ Outplays Competition to Win USC Libraries Scripter Award

    ‘The Imitation Game’ Outplays Competition to Win USC Libraries Scripter Award

  4. Land Rover Discovery Sport: Taming Iceland

    Land Rover Discovery Sport: Taming Iceland

  5. Bacteria: New Weapon in Cancer Battle, CIO 2015 Study Suggests

    Bacteria: New Weapon in Cancer Battle, CIO 2015 Study Suggests

  6. Nuvo Research® Reports Topline Results of Phase 2 Study of WF10™ for the Treatment of Allergic Rhinitis

    Nuvo Research® Reports Topline Results of Phase 2 Study of WF10™ for the Treatment of Allergic Rhinitis

  7. Murad Transforms Daily Routine into Anti-Aging Treatment with Debut of Youth Builder® Bodycare

    Murad Transforms Daily Routine into Anti-Aging Treatment with Debut of Youth Builder® Bodycare

  8. U.S. FDA Approves IMBRUVICA® (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM)

    U.S. FDA Approves IMBRUVICA® (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM)

  9. Cannabis Science (CBIS) Issues Upbeat Report on its Subsidiary, Michigan Green Technologies (MGT), as Historic Michigan Milestone is Reached with New Hemp Legislation

    Cannabis Science (CBIS) Issues Upbeat Report on its Subsidiary, Michigan Green Technologies (MGT), as Historic Michigan Milestone is Reached with New Hemp Legislation

  10. Research and Markets: Notch Signaling Pathway in Oncology Drug Pipeline Report 2015

    Research and Markets: Notch Signaling Pathway in Oncology Drug Pipeline Report 2015

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.